# A Case of Metastatic Vulvar Choriocarcinoma Misdiagnosed as Vulvar Abscess: A Case Report

**Authors:** Alita Mrema, Prudence H. Kiwia, Shaban J. Shaban, Anwar Z. Mohamed, Latifa Rajab Abdallah, Rajabu Kiaratu, John Mahoyogo, Agapiti Chuwa, David H. Mvunta

PMC · DOI: 10.1155/2024/9918452 · 2024-08-27

## TL;DR

A rare case of metastatic vulvar choriocarcinoma was initially misdiagnosed as a vulvar abscess, highlighting the challenges in diagnosing this condition.

## Contribution

The case emphasizes the importance of using serum β-hCG testing and suggests a simple urine pregnancy test as a diagnostic tool in resource-limited settings.

## Key findings

- The patient's condition was misdiagnosed as a vulvar abscess for months before correct diagnosis with β-hCG testing.
- EMA-CO chemotherapy and emergency radiotherapy were effective after stabilization.
- A simple urine pregnancy test with serial dilutions can aid diagnosis in low-resource settings.

## Abstract

Background: Metastatic vulvar choriocarcinoma, a rare ectopic gestational trophoblastic neoplasia (GTN), often presents a diagnostic challenge due to its mimicry of other conditions, particularly in resource-limited settings. Its primary symptom is abnormal vaginal bleeding without a clear cause. Consequently, diagnosing and managing it poses difficulties for many low-resource health facilities, as evidenced by the current case.

Case Presentation: We present the case of a 25-year-old, P2+2+2L2, who had a large painless, bleeding vulva mass for nearly 5 months. This followed a spontaneous abortion the month prior. The mass gradually increased in size and was accompanied by fever, pus discharge, and weight loss. Despite being treated at multiple health facilities for a vulvar abscess, there was no improvement. A diagnosis was finally made at a tertiary facility where elevated quantitative serum beta-human chorionic gonadotropin (hCG) (β-hCG) was noted. Due to uncontrollable vulva bleeding, she was referred to another tertiary facility for emergency radiotherapy. Following stabilization, chemotherapy was administered using the EMA-CO protocol.

Conclusion: The report highlights the difficulty in diagnosing vulvar choriocarcinoma, underscoring the importance of a high index of suspicion. Clinical tests such as serum (β-hCG) and imaging studies are crucial for diagnosis. In resource-limited settings, a simple strip-based urine pregnancy test with serial dilutions can be sufficient for diagnosing and managing vulvar choriocarcinoma.

## Linked entities

- **Proteins:** CGA (glycoprotein hormones, alpha polypeptide)
- **Diseases:** choriocarcinoma (MONDO:0003508)

## Full-text entities

- **Genes:** CGB5 (chorionic gonadotropin subunit beta 5) [NCBI Gene 93659] {aka CGB, HCG}
- **Diseases:** Vulvar Choriocarcinoma (MESH:D002822), Vulvar Abscess (MESH:D014845), abortion (MESH:D000026), bleeding vulva mass (MESH:D014846), pus discharge (MESH:D013492), weight loss (MESH:D015431), vaginal bleeding (MESH:D014592), fever (MESH:D005334), GTN (MESH:D031901)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11371442/full.md

---
Source: https://tomesphere.com/paper/PMC11371442